Skip to content

Usefulness in double bare type metallic stent insertion for distal biliary tract obstruction in the unresectable malignancy. -multi-center prospective randomized trial-

Usefulness in double bare type metallic stent insertion for distal biliary tract obstruction in the unresectable malignancy. -multi-center prospective randomized trial- - Usefulness in double bare type metallic stent insertion for distal biliary tract obstruction in the unresectable malignancy. -multi-center prospective randomized trial-

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000016513
Enrollment
80
Registered
2015-02-11
Start date
2015-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

unresectable distal biliary obstruction

Interventions

Sponsors

Fukushima Medical University Aizu Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Having lower part biliary tract stenosis in the unresectable malignancy. 2. Age is a patient 20 years or older at the agreement acquisition. 3.Patients who understand and are willing to give a written informed consent about participation

Exclusion criteria

Exclusion criteria: 1.Performance Status (PS)4. 2.The patient who has serious disease. 3.The pacient with anticoagulant therapy. 4.The woman becomes pregnant or might be pregnant. 5.The patient who has bile duct stenosis in the liver from a hepatic portal region. 6.Approach from papilla is difficult. 7.Insertion of the endoscope is impossible. 8.Not to include the case that removed duodenal confinement by patient. 9.The patient was judged the physician to be inappropriate.

Design outcomes

Primary

MeasureTime frame
stent patency obstruction rate

Countries

Japan

Contacts

Public ContactRyo IGARASHI

Fukushima Medical University Aizu Medical Center gastroenterology

ryo-i@fmu.ac.jp(0242)75-2100

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026